Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Globus Medical Inc
(NY:
GMED
)
72.05
+2.37 (+3.40%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Globus Medical Inc
< Previous
1
2
3
4
5
6
7
Next >
Investors seeking growth at a reasonable cost should explore NYSE:GMED.
December 25, 2023
In the world of growth stocks, NYSE:GMED shines as a value proposition.
Via
Chartmill
Assessing Globus Medical: Insights From 5 Financial Analysts
December 20, 2023
Via
Benzinga
3 Stocks at the Forefront of Medical Robotics
December 10, 2023
Although the concept of medical robotics stocks is incredibly risky, the sector also offers tremendous upside for the intrepid.
Via
InvestorPlace
For those who appreciate growth without the sticker shock, NYSE:GMED is worth considering.
December 04, 2023
GLOBUS MEDICAL INC - A (NYSE:GMED) is not too expensive for the growth it is showing.
Via
Chartmill
NYSE:GMED: a strong growth stock preparing for the next leg up?.
November 17, 2023
GLOBUS MEDICAL INC - A (NYSE:GMED) qualifies as a high growth stock and is consolidating.
Via
Chartmill
Investors should take note of NYSE:GMED, a growth stock that remains attractively priced.
November 13, 2023
Despite its growth, NYSE:GMED remains within the realm of affordability.
Via
Chartmill
Expert Ratings for Globus Medical
November 08, 2023
Via
Benzinga
Globus Medical: Q3 Earnings Insights
November 07, 2023
Via
Benzinga
NYSE:GMED is showing good growth, while it is not too expensive.
October 23, 2023
NYSE:GMED, a growth stock which is not overvalued.
Via
Chartmill
What 8 Analyst Ratings Have To Say About Globus Medical
October 20, 2023
Via
Benzinga
Globus Medical (GMED) Q3 2023 Earnings Call Transcript
November 07, 2023
GMED earnings call for the period ending September 30, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Globus Medical Reports Third Quarter 2023 Results
November 07, 2023
From
Globus Medical
Via
GlobeNewswire
Globus Medical Schedules Third Quarter Earnings Release and Conference Call
October 24, 2023
From
Globus Medical
Via
GlobeNewswire
Five-Year Study Outcomes of the NuVasive Simplify Cervical Disc were Presented at the North American Spine Society 38th Annual Meeting
October 24, 2023
From
Globus Medical
Via
GlobeNewswire
The Latest Analyst Ratings for Globus Medical
September 05, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 20, 2023
October 20, 2023
Via
Benzinga
Twenty Years of the NuVasive XLIF Procedure Celebrated at the Society for Minimally Invasive Spine Surgery 2023 Annual Forum
October 10, 2023
From
Globus Medical
Via
GlobeNewswire
Globus Medical and NuVasive to Sponsor and Participate at EUROSPINE 2023
September 27, 2023
From
Globus Medical
Via
GlobeNewswire
Where Globus Medical Stands With Analysts
August 04, 2023
Via
Benzinga
Globus Medical (GMED) Q2 2023 Earnings Call Transcript
August 03, 2023
GMED earnings call for the period ending June 30, 2023.
Via
The Motley Fool
Globus Medical's Untapped Potential Beyond The NUVA Transaction; Analyst Turns Bullish
September 19, 2023
Stifel analyst Mathew Blackman upgraded Globus Medical, Inc. (NYSE: GMED) to Buy from Hold,
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 19, 2023
September 19, 2023
Via
Benzinga
NuVasive Specialized Orthopedics Launches Precice Bone Transport in International Markets
September 07, 2023
From
Globus Medical
Via
GlobeNewswire
Expert Ratings for Globus Medical
May 31, 2023
Via
Benzinga
Analyst Expectations for Globus Medical's Future
May 05, 2023
Via
Benzinga
Globus Medical Completes Merger with NuVasive
September 01, 2023
From
Globus Medical
Via
GlobeNewswire
Globus Medical Reports Second Quarter 2023 Results
August 03, 2023
From
Globus Medical
Via
GlobeNewswire
Globus Medical Announces Launch of the MARVEL™ Growing Rod System, the company’s first product designed specifically for early onset scoliosis
July 31, 2023
MARVEL™ is Globus Medical’s second major release this year in the pediatric scoliosis space
From
Globus Medical
Via
GlobeNewswire
Globus Medical Schedules Second Quarter Earnings Release and Conference Call
July 13, 2023
From
Globus Medical
Via
GlobeNewswire
Globus Medical Announces FDA Approval for its Non-Fusion Scoliosis Correction System, the Latest Advancement for Young Patients with Idiopathic Scoliosis
May 15, 2023
REFLECT™ is approved through the FDA’s Humanitarian Device Exemption pathway
From
Globus Medical
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.